Nearly 40% of adolescent athletes report anterior knee pain regardless of maturation status, age, sex or sport played.


Journal

Physical therapy in sport : official journal of the Association of Chartered Physiotherapists in Sports Medicine
ISSN: 1873-1600
Titre abrégé: Phys Ther Sport
Pays: England
ID NLM: 100940513

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 18 02 2021
revised: 21 06 2021
accepted: 25 06 2021
pubmed: 3 7 2021
medline: 25 8 2021
entrez: 2 7 2021
Statut: ppublish

Résumé

To report point prevalence of anterior knee pain (AKP) in adolescent athletes by (1) maturation status, (2) chronological age, (3) sex, and (4) primary sport. Cross-sectional. Male and female participants aged 11-15 years were recruited from specialised sports programs for basketball, volleyball, Australian Rules Football and tennis. Standing height, sitting height, and body mass were measured and used to calculate maturity status. Past injury history, self-reported physical activity, and Victorian Institute of Sport Assessment Questionnaire Patellar Tendon (VISA-P) questionnaires were completed. Anterior knee pain was defined as any pain experienced on the anterior surface of the knee and recorded using a visual analogue scale (VAS). A single leg decline squat (SLDS) was performed for provocation of AKP. Two hundred and seventeen male and female adolescent athletes participated in this study. Twenty participants were excluded from data analysis. Point prevalence of AKP was 39% (N = 76). Average self-reported physical activity/week was 7.9 ± 4.1 h of their specialised sport and 2.0 ± 2.0 h of other physical activity/week. Maturation status, chronological age, sex nor primary sporting program was statistically significant in explaining the presence or absence of AKP. Due to the right-skewed maturation sample, the authors cannot state conclusively that maturation status was not associated with AKP. Nearly 40% of this cohort reported AKP during a pain provocation test. The presence of AKP was not explained by maturation status, age, sex or primary sport program. Given the chronic nature of AKP and future morbidity reported, this high prevalence provides rationale for intervention or prevention studies targeting younger athletes.

Identifiants

pubmed: 34214873
pii: S1466-853X(21)00109-7
doi: 10.1016/j.ptsp.2021.06.005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

29-35

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None declared.

Auteurs

Meaghan Harris (M)

The University of Newcastle, School of Environmental and Life Sciences, Ourimbah, NSW, Australia. Electronic address: meaghan.harris@uon.edu.au.

Suzi Edwards (S)

The University of Newcastle, School of Environmental and Life Sciences, Ourimbah, NSW, Australia; The University of Newcastle, Priority Research Centre for Physical Activity and Nutrition, Callaghan, NSW, Australia.

Ebonie Rio (E)

La Trobe University Sport and Exercise Medicine Research Centre, La Trobe University, Bundoora, VIC, Australia.

Jill Cook (J)

La Trobe University Sport and Exercise Medicine Research Centre, La Trobe University, Bundoora, VIC, Australia.

Sebastiano Cencini (S)

Department of Medicine, Surgery and Neuroscience, University of Siena, Viale Mario Bracci, 16 - Siena (Santa Maria alle Scotte Hospital), Italy.

Madeline Claire Hannington (MC)

La Trobe University Sport and Exercise Medicine Research Centre, La Trobe University, Bundoora, VIC, Australia.

Christian Bonello (C)

La Trobe University Sport and Exercise Medicine Research Centre, La Trobe University, Bundoora, VIC, Australia.

Sean Docking (S)

La Trobe University Sport and Exercise Medicine Research Centre, La Trobe University, Bundoora, VIC, Australia; Monash Department of Clinical Epidemiology, Cabrini Institute, Monash University, Clayton, VIC, Australia; Cabrini Institute, Cabrini Health, Malvern, VIC, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH